The CMA investigated the anticipated acquisition by Perrigo Company plc of Omega Pharma Invest NV.
|Phase 1 date||Action|
|9 April 2015||Decision published|
|9 March 2015||Decision announced|
|13 January 2015 to 26 January 2015||Invitation to comment|
|13 January 2015||Launch of merger inquiry|
CMA clearance decision
9 March 2015: The CMA has cleared the anticipated acquisition by Perrigo Company plc of Omega Pharma Invest NV. The full text of the decision is available below.
- Full text decision (9.4.15)
Launch of merger inquiry
13 January 2015: The CMA announced the launch of its merger inquiry by notice to the parties.
- Commencement of initial period notice (13.1.15)
Invitation to comment: Now closed
13 January 2015: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.
Please send written representations about any competition or public interest to:
Competition and Markets Authority
Published: 13 January 2015
Updated: 9 April 2015
Opened: 13 January 2015
Closed: 9 April 2015
- Full text of the decision published.
- First published.